Adaptimmune Therapeutics Current Ratio 2015-2018 | ADAP

Current and historical current ratio for Adaptimmune Therapeutics (ADAP) from 2015 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Adaptimmune Therapeutics current ratio for the three months ending June 30, 2018 was 3.82.
Adaptimmune Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $0.16B $0.04B 3.82
2018-03-31 $0.20B $0.05B 3.77
2017-12-31 $0.23B $0.07B 3.10
2017-09-30 $0.25B $0.07B 3.70
2017-06-30 $0.24B $0.03B 7.86
2017-03-31 $0.22B $0.03B 6.99
2016-12-31 $0.20B $0.04B 4.94
2016-09-30 $0.20B $0.02B 8.81
2016-06-30 $0.22B $0.02B 10.84
2016-03-31 $0.24B $0.02B 12.03
2015-12-31 $0.26B $0.03B 9.43
2015-09-30 $0.29B $0.03B 8.52
2015-06-30 $0.30B $0.03B 11.03
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.14B $0.05B 2.94
2014-06-30 $0.05B $0.05B 1.02
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.016B $0.038B
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.620B 14.99
Gilead Sciences (GILD) United States $94.983B 10.54
Biogen (BIIB) United States $64.544B 13.68
Celgene (CELG) United States $57.964B 11.57
Illumina (ILMN) United States $46.026B 57.66
Vertex Pharmaceuticals (VRTX) United States $44.899B 102.14
Regeneron Pharmaceuticals (REGN) United States $42.123B 23.68
Alexion Pharmaceuticals (ALXN) United States $28.056B 21.09
BioMarin Pharmaceutical (BMRN) United States $18.331B 0.00
Incyte (INCY) United States $14.043B 471.86
Seattle Genetics (SGEN) United States $11.401B 0.00
Sarepta Therapeutics (SRPT) United States $8.918B 0.00
QIAGEN (QGEN) Netherlands $8.196B 26.80
Alnylam Pharmaceuticals (ALNY) United States $7.716B 0.00
Exact Sciences (EXAS) United States $7.567B 0.00
BeiGene (BGNE) Cayman Islands $6.707B 0.00
Bio-Techne Corp (TECH) United States $6.702B 44.82
Bluebird Bio (BLUE) United States $6.537B 0.00
Alkermes (ALKS) Ireland $6.237B 0.00
Amarin (AMRN) Ireland $5.762B 0.00
Galapagos (GLPG) Belgium $5.520B 0.00
Exelixis (EXEL) United States $4.849B 15.80
Immunomedics (IMMU) United States $4.475B 0.00
Ligand Pharmaceuticals (LGND) United States $3.957B 35.05
Myriad Genetics (MYGN) United States $3.307B 35.13
Array BioPharma (ARRY) United States $3.226B 0.00
Horizon Pharma Public (HZNP) Ireland $3.178B 17.99
Ultragenyx Pharmaceutical (RARE) United States $3.176B 0.00
Emergent Biosolutions (EBS) United States $3.038B 24.20
MorphoSys AG Unsponsored ADR (MOR) Germany $3.034B 0.00
GUARDANT HEALTH (GH) United States $2.991B 0.00
Blueprint Medicines (BPMC) United States $2.981B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.830B 0.00
Ascendis Pharma (ASND) Denmark $2.798B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.776B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.619B 0.00
Repligen (RGEN) United States $2.416B 81.10
Halozyme Therapeutics (HALO) United States $2.361B 31.46
Acceleron Pharma (XLRN) United States $2.360B 0.00
China Biologic Products (CBPO) China $2.352B 16.17
Genomic Health (GHDX) United States $2.309B 128.80
Amicus Therapeutics (FOLD) United States $2.264B 0.00
MyoKardia (MYOK) United States $2.223B 0.00
Akcea Therapeutics (AKCA) United States $2.019B 0.00
Medicines (MDCO) United States $1.985B 0.00
Arena Pharmaceuticals (ARNA) United States $1.974B 0.00
Global Blood Therapeutics (GBT) United States $1.968B 0.00
AnaptysBio (ANAB) United States $1.893B 0.00
REGENXBIO (RGNX) United States $1.886B 29.63
Cambrex (CBM) United States $1.877B 15.05
Allakos (ALLK) United States $1.815B 0.00
Reata Pharmaceuticals (RETA) United States $1.804B 0.00
Spark Therapeutics (ONCE) United States $1.794B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.768B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.701B 0.00
Puma Biotechnology (PBYI) United States $1.604B 0.00
Innoviva (INVA) United States $1.597B 10.25
Aimmune Therapeutics (AIMT) United States $1.596B 0.00
Atara Biotherapeutics (ATRA) United States $1.586B 0.00
Denali Therapeutics (DNLI) United States $1.582B 0.00
G1 THERAPEUTICS (GTHX) United States $1.564B 0.00
Myovant Sciences (MYOV) United Kingdom $1.433B 0.00
Sangamo Therapeutics (SGMO) United States $1.412B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.404B 0.00
WAVE Life Sciences (WVE) Singapore $1.395B 0.00
Clovis Oncology (CLVS) United States $1.388B 0.00
Rubius Therapeutics (RUBY) United States $1.354B 0.00
Editas Medicine (EDIT) United States $1.311B 0.00
Mirati Therapeutics (MRTX) United States $1.295B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Insmed (INSM) United States $1.264B 0.00
Solid Biosciences (SLDB) United States $1.224B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.212B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.152B 2200.00
NeoGenomics (NEO) United States $1.123B 196.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.102B 0.00
Cellectis (CLLS) France $1.090B 0.00
DBV Technologies (DBVT) France $1.079B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.069B 0.00
Retrophin (RTRX) United States $1.033B 0.00
Audentes Therapeutics (BOLD) United States $1.007B 0.00
Intra-Cellular Therapies (ITCI) United States $0.996B 0.00
UniQure (QURE) Netherlands $0.994B 0.00
Intellia Therapeutics (NTLA) United States $0.962B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.951B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.951B 0.00
Lion Biotechnologies (IOVA) United States $0.945B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.921B 0.00
Revance Therapeutics (RVNC) United States $0.885B 0.00
Aptinyx (APTX) United States $0.874B 0.00
Athenex (ATNX) United States $0.862B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.859B 0.00
Acorda Therapeutics (ACOR) United States $0.848B 17.68
Viking Therapeutics (VKTX) United States $0.839B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.838B 0.00
Coherus BioSciences (CHRS) United States $0.836B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.787B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Cara Therapeutics (CARA) United States $0.773B 0.00
Fate Therapeutics (FATE) United States $0.755B 0.00
Apellis Pharmaceuticals (APLS) United States $0.755B 0.00
Heska (HSKA) United States $0.752B 64.70
Inotek Pharmaceuticals (RCKT) United States $0.745B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.742B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.727B 0.00
Novavax (NVAX) United States $0.723B 0.00
Epizyme (EPZM) United States $0.693B 0.00
CytomX Therapeutics (CTMX) United States $0.692B 0.00
Dynavax Technologies (DVAX) United States $0.682B 0.00
AVROBIO (AVRO) United States $0.657B 0.00
ANI Pharmaceuticals (ANIP) United States $0.650B 12.88
NuCana Sponsored ADR (NCNA) United Kingdom $0.646B 0.00
Mesoblast (MESO) Australia $0.642B 0.00
AC Immune SA (ACIU) Switzerland $0.635B 0.00
ObsEva SA (OBSV) Switzerland $0.600B 0.00
Anika Therapeutics (ANIK) United States $0.598B 25.15
MiMedx (MDXG) United States $0.590B 25.29
UROGEN PHARMA (URGN) Israel $0.577B 0.00
Kura Oncology (KURA) United States $0.546B 0.00
Principia Biopharma (PRNB) United States $0.539B 0.00
RA PHARMCTL INC (RARX) United States $0.538B 0.00
Scholar Rock Holding (SRRK) United States $0.527B 0.00
Arcus Biosciences (RCUS) United States $0.524B 0.00
Prothena (PRTA) Ireland $0.517B 0.00
Five Prime Therapeutics (FPRX) United States $0.509B 0.00
ARVINAS INC (ARVN) United States $0.500B 0.00
Inovio Pharmaceuticals (INO) United States $0.498B 0.00
Aduro Biotech (ADRO) United States $0.496B 0.00
Kezar Life Sciences (KZR) United States $0.487B 0.00
Vericel (VCEL) United States $0.484B 0.00
Stemline Therapeutics (STML) United States $0.484B 0.00
UNITY Biotechnology (UBX) $0.478B 0.00
Senesco Technologies (ELOX) United States $0.459B 0.00
Abeona Therapeutics (ABEO) United States $0.448B 0.00
BeyondSpring (BYSI) United States $0.446B 0.00
Kindred Biosciences (KIN) United States $0.435B 0.00
GRITSTONE ONCLG (GRTS) United States $0.433B 0.00
MediciNova (MNOV) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.428B 0.00
Verastem (VSTM) United States $0.419B 0.00
Liquidia Technologies (LQDA) United States $0.416B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.410B 0.00
Zymeworks (ZYME) Canada $0.408B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 0.00
Cytokineticsorporated (CYTK) United States $0.397B 0.00
Sorrento Therapeutics (SRNE) United States $0.395B 67.60
Keryx Biopharmaceuticals (KERX) United States $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.381B 0.00
UROVANT SCIENCS (UROV) United States $0.381B 0.00
PDL BioPharma (PDLI) United States $0.369B 5.18
Merus (MRUS) Netherlands $0.367B 0.00
Replimune (REPL) United States $0.366B 0.00
Osiris Therapeutics (OSIR) United States $0.362B 0.00
MeiraGTx Holdings (MGTX) United States $0.360B 0.00
KODIAK SCIENCES (KOD) United States $0.355B 0.00
Eidos Therapeutics (EIDX) United States $0.350B 0.00
ResTORbio (TORC) United States $0.334B 0.00
Magenta Therapeutics (MGTA) United States $0.332B 0.00
SUTRO BIOPHARMA (STRO) United States $0.332B 0.00
Albireo Pharma (ALBO) United States $0.331B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.320B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.316B 0.00
Selecta Biosciences (SELB) United States $0.309B 0.00
Kala Pharmaceuticals (KALA) United States $0.307B 0.00
Geron (GERN) United States $0.307B 0.00
Evelo Biosciences (EVLO) United States $0.305B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.304B 0.00
MannKind (MNKD) United States $0.304B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.296B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.296B 0.00
Kadmon Holdings (KDMN) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.292B 0.00
Proteostasis Therapeutics (PTI) United States $0.292B 0.00
Unum Therapeutics (UMRX) United States $0.288B 0.00
Celcuity (CELC) United States $0.287B 0.00
Adverum Biotechnologies (ADVM) United States $0.282B 0.00
Athersys (ATHX) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.281B 0.00
Cellular Biomedicine (CBMG) United States $0.279B 0.00
Seres Therapeutics (MCRB) United States $0.266B 0.00
Axovant Sciences (AXON) United Kingdom $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.256B 0.00
Krystal Biotech (KRYS) United States $0.249B 0.00
Celyad SA (CYAD) Belgium $0.249B 0.00
Arbutus Biopharma (ABUS) Canada $0.240B 0.00
Syros Pharmaceuticals (SYRS) United States $0.239B 0.00
Kamada (KMDA) Israel $0.237B 18.41
TOCAGEN INC (TOCA) United States $0.236B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.234B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.233B 0.00
Synlogic (SYBX) United States $0.230B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Agenus (AGEN) United States $0.222B 0.00
BioDelivery Sciences (BDSI) United States $0.217B 0.00
NantKwest (NK) United States $0.215B 0.00
Allena Pharmaceuticals (ALNA) United States $0.214B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.205B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.202B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Idera Pharmaceuticals (IDRA) United States $0.191B 0.00
Compugen (CGEN) Israel $0.187B 0.00
Mersana Therapeutics (MRSN) United States $0.186B 0.00
Cerecor (CERC) United States $0.184B 18.83
Constellation Pharmaceuticals (CNST) United States $0.182B 0.00
Cohbar (CWBR) United States $0.178B 0.00
Clearside Biomedical (CLSD) United States $0.175B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.170B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Intec Pharma (NTEC) Israel $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
OVID THERAPEUTC (OVID) United States $0.152B 0.00
Signal Genetics (MGEN) United States $0.145B 0.00
PSivida (EYPT) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.136B 0.00
Cue Biopharma (CUE) United States $0.136B 0.00
Mustang Bio (MBIO) United States $0.136B 0.00
Monster Digital (INNT) United States $0.131B 0.00
Menlo Therapeutics (MNLO) United States $0.130B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
XBiotech (XBIT) United States $0.127B 0.00
VBI Vaccines (VBIV) United States $0.126B 0.00
Tapimmune (MRKR) United States $0.126B 0.00
XOMA (XOMA) United States $0.126B 13.27
Anavex Life Sciences (AVXL) United States $0.125B 0.00
Eleven Biotherapeutics (SESN) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.124B 0.00
Motif Bio Plc (MTFB) United States $0.123B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Provention Bio (PRVB) United States $0.114B 0.00
Catalyst Biosciences (CBIO) United States $0.113B 0.00
ITUS (ANIX) United States $0.113B 0.00
Axsome Therapeutics (AXSM) United States $0.109B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.101B 0.00
BioXcel Therapeutics (BTAI) United States $0.098B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Orgenesis (ORGS) United States $0.097B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.097B 0.00
Leap Therapeutics (LPTX) United States $0.096B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.095B 0.00
Aptevo Therapeutics (APVO) United States $0.091B 0.00
Chiasma (CHMA) United States $0.091B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.089B 0.00
Prima BioMed (IMMP) Australia $0.088B 0.00
OncoSec Medical (ONCS) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.084B 0.00
ScPharmaceuticals (SCPH) United States $0.082B 0.00
Ophthotech (OPHT) United States $0.082B 0.53
NewLink Genetics (NLNK) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Alcobra (ARCT) United States $0.072B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.071B 0.00
Sophiris Bio (SPHS) United States $0.071B 0.00
BIONANO GENOMIC (BNGO) United States $0.070B 0.00
Evogene (EVGN) Israel $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
Bellerophon Therapeutics (BLPH) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.054B 0.00
Oncolytics Biotech (ONCY) Canada $0.053B 0.00
Fortress Biotech (FBIO) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Celsion (CLSN) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
GTx (GTXI) United States $0.043B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
CytRx (CYTR) United States $0.028B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 48.67
Akari Therapeutics (AKTX) United Kingdom $0.023B 0.00
Arsanis (ASNS) United States $0.021B 0.00
Histogenics (HSGX) United States $0.021B 0.00
Soligenix (SNGX) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Gemphire Therapeutics (GEMP) United States $0.020B 0.00
TrovaGene (TROV) United States $0.019B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 5.58
Novogen (KZIA) Australia $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Neuralstem (CUR) United States $0.013B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00